Cutera Enters into Settlement Agreement with Voce Capital
January 08, 2015 at 10:08 pm
Share
On January 8, 2015, Cutera, Inc. announced that it has entered into an agreement with Voce Capital Management and J. Daniel Plants. The Company stated that the agreement sets forth the parties' agreements and understandings concerning the election of J. Daniel Plants to the board of directors of the Company, and undertakings of Voce Capital Management and J. Daniel Plants not to engage in certain actions prior to the 30th day before the deadline for stockholder nominations of director candidates to stand for election at the 2016 annual meeting of stockholders, including but not limited to the ownership of Voce Capital in the shares not exceeding 14.9% of the outstanding shares.
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Companyâs Cutera Core segment consists of the Companyâs systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Companyâs AviClear segment consists of the AviClear business. The Companyâs acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.